Business Description
Middle East Healthcare Co
ISIN : SA141H01UKH9
Description
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company. The company's reportable segments are Inpatient Services, Outpatient Services, Pharmacy Sales and Others. The majority of revenue is derived from the Inpatient Services segment.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 1.3 | |||||
Debt-to-EBITDA | 3.96 | |||||
Interest Coverage | 2 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.64 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13 | |||||
3-Year EBITDA Growth Rate | 37.2 | |||||
3-Year EPS without NRI Growth Rate | 33.4 | |||||
3-Year Book Growth Rate | 12.1 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 6.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 23.89 | |||||
9-Day RSI | 30.02 | |||||
14-Day RSI | 34.03 | |||||
3-1 Month Momentum % | -19.75 | |||||
6-1 Month Momentum % | -12.89 | |||||
12-1 Month Momentum % | -45.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.48 | |||||
Quick Ratio | 1.42 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 13.36 | |||||
Days Sales Outstanding | 224.58 | |||||
Days Payable | 53.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.65 | |||||
Dividend Payout Ratio | 0.28 | |||||
Forward Dividend Yield % | 1.65 | |||||
5-Year Yield-on-Cost % | 1.66 | |||||
Shareholder Yield % | 2.14 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.08 | |||||
Operating Margin % | 11.68 | |||||
Net Margin % | 5.34 | |||||
EBITDA Margin % | 19.85 | |||||
FCF Margin % | -0.62 | |||||
OCF Margin % | 17.09 | |||||
ROE % | 9.1 | |||||
ROA % | 3.13 | |||||
ROIC % | 6.83 | |||||
3-Year ROIIC % | 23.88 | |||||
ROC (Joel Greenblatt) % | 8.21 | |||||
ROCE % | 9.27 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 16.65 | |||||
Forward PE Ratio | 16.01 | |||||
PE Ratio without NRI | 16.73 | |||||
Shiller PE Ratio | 14.69 | |||||
Price-to-Owner-Earnings | 144.16 | |||||
PEG Ratio | 0.49 | |||||
PS Ratio | 0.9 | |||||
PB Ratio | 1.47 | |||||
Price-to-Tangible-Book | 1.51 | |||||
Price-to-Operating-Cash-Flow | 5.21 | |||||
EV-to-EBIT | 14.27 | |||||
EV-to-EBITDA | 8.49 | |||||
EV-to-Revenue | 1.69 | |||||
EV-to-Forward-Revenue | 2.39 | |||||
EV-to-FCF | -279.69 | |||||
Price-to-GF-Value | 0.38 | |||||
Price-to-Projected-FCF | 3.07 | |||||
Price-to-Median-PS-Value | 0.44 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.67 | |||||
Price-to-Graham-Number | 1.06 | |||||
Earnings Yield (Greenblatt) % | 7 | |||||
FCF Yield % | -0.7 | |||||
Forward Rate of Return (Yacktman) % | 21.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Middle East Healthcare Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ï·¼) | 3,134.128 | ||
| EPS (TTM) (ï·¼) | 1.82 | ||
| Beta | 1.6119 | ||
| 3-Year Sharpe Ratio | -0.52 | ||
| 3-Year Sortino Ratio | -0.72 | ||
| Volatility % | 36.77 | ||
| 14-Day RSI | 34.03 | ||
| 14-Day ATR (ï·¼) | 0.689871 | ||
| 20-Day SMA (ï·¼) | 31.779 | ||
| 12-1 Month Momentum % | -45.01 | ||
| 52-Week Range (ï·¼) | 28.66 - 60.15 | ||
| Shares Outstanding (Mil) | 92.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Middle East Healthcare Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Middle East Healthcare Co Stock Events
| Event | Date | Price (ï·¼) | ||
|---|---|---|---|---|
| SAR 0.500000 Cash Dividend | 2026-07-08 | 31.74 (-0.81%) | ||
| SAR 0.500000 Cash Dividend | 2025-07-09 | 57.90 (-0.77%) |
Show
Entries
Middle East Healthcare Co Frequently Asked Questions
What is Middle East Healthcare Co(SAU:4009)'s stock price today?
The current price of SAU:4009 is ï·¼30.28. The 52 week high of SAU:4009 is ï·¼60.15 and 52 week low is ï·¼28.66.
When is next earnings date of Middle East Healthcare Co(SAU:4009)?
The next earnings date of Middle East Healthcare Co(SAU:4009) is .
Does Middle East Healthcare Co(SAU:4009) pay dividends? If so, how much?
The Dividend Yield %  of Middle East Healthcare Co(SAU:4009) is 1.65% (As of Today), Highest Dividend Payout Ratio of Middle East Healthcare Co(SAU:4009) was 1.07. The lowest was 0.25. And the median was 0.58. The  Forward Dividend Yield % of Middle East Healthcare Co(SAU:4009) is 1.65%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Middle East Healthcare Co
No articles.